XML 81 R69.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments and Fair Value Measurements (Narrative) (Details) - USD ($)
6 Months Ended 9 Months Ended
Oct. 02, 2020
Oct. 02, 2020
Apr. 04, 2020
Feb. 19, 2020
Dec. 31, 2019
Oct. 07, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Asset acquisition contingent consideration recognized     $ 1,000,000.0      
Settlements $ 500,000 $ 1,000,000        
Fair value 5,401,000 5,401,000     $ 4,200,000  
Derivative instruments net loss to be reclassified to net income during next twelve months   4,300,000        
Accrued expenses and other current liabilities            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Fair value 1,200,000 1,200,000        
Other long-term liabilities            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Fair value $ 4,200,000 $ 4,200,000        
Chinese Venture Capital Fund            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Equity method investment ownership (percent) 6.60% 6.60%        
InoMec Ltd            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Contingent consideration, range of outcomes, value, low       $ 0    
Contingent consideration, range of outcomes, value, high       3,500,000    
Fair value of contingent consideration recognized       $ 1,700,000    
Business acquisition contingent liability $ 1,700,000 $ 1,700,000        
US BioDesign LLC            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Contingent consideration, range of outcomes, value, low           $ 0
Contingent consideration, range of outcomes, value, high           5,500,000
Fair value of contingent consideration recognized           $ 4,200,000
Contingent consideration liabilities recorded for acquisitions   500,000        
Business acquisition contingent liability $ 3,700,000 $ 3,700,000